Literature DB >> 7824725

Giant ulcers of the esophagus in patients with human immunodeficiency virus: clinical, radiographic, and pathologic findings.

S Sor1, M S Levine, T E Kowalski, I Laufer, S E Rubesin, H Herlinger.   

Abstract

PURPOSE: To determine the causes of giant esophageal ulcers in patients with human immunodeficiency virus (HIV) and whether clinical or radiographic criteria can be used to differentiate the infections that cause these ulcers.
MATERIALS AND METHODS: From January 1990 through December 1993, giant esophageal ulcers ( > or = 1 cm in diameter) were found in 21 HIV-positive patients (19 men and two women 23-66 years of age; mean, 39 years). The radiographic findings were reviewed and correlated with clinical, endoscopic, and pathologic findings.
RESULTS: In 16 patients, the ulcers were caused by HIV, in three by cytomegalovirus (CMV), and in two by CMV and HIV. The clinical and radiographic findings were the same for the two types of ulcers. However, HIV ulcers responded to treatment with steroids, and CMV ulcers responded to treatment with ganciclovir.
CONCLUSION: It is not possible to differentiate HIV from CMV ulcers on the basis of clinical or radiographic criteria; thus, endoscopy is necessary for a definitive diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7824725     DOI: 10.1148/radiology.194.2.7824725

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Esophageal actinomycosis: a case report and review of radiographic findings.

Authors:  Rodney D Welling; Diana M Cardona; William M Thompson
Journal:  J Radiol Case Rep       Date:  2009-12-01

Review 2.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 3.  History and Evolution of the Barium Swallow for Evaluation of the Pharynx and Esophagus.

Authors:  Marc S Levine; Stephen E Rubesin
Journal:  Dysphagia       Date:  2017-01-18       Impact factor: 2.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.